// App-Quantinova.ai

PO‐076 : Feasibility of administration of ofatumumab infusions in patients unable to tolerate rituximab

Researchers

Presenter

  • L Chen

Principal Investigators

  • R Shah

  • K Cywnarksi

  • R Joshi

  • J Lambert

  • C McNamara

  • S Mohamedbhai

  • A Virchis

  • K Ardeshna

Medical Centers

  • King's College Hosptial NHS Foundation Trust, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • N/A

Biomarkers

  • B-lymphocyte antigen CD20

Drug/Treatment

  • ofatumumab Intravenous

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved